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Carbonic anhydrase IX is a pH-stat that sets an acidic tumour
extracellular pH in vivo
Shen-Han Lee1,2, Dominick McIntyre1, Davina Honess1, Alzbeta Hulikova3, Jesús Pacheco-Torres4, Sebastián Cerdán5, Pawel Swietach3,
Adrian L. Harris 6 and John R. Grifﬁths1
BACKGROUND: Tumour carbonic anhydrase IX (CAIX), a hypoxia-inducible tumour-associated cell surface enzyme, is thought to
acidify the tumour microenvironment by hydrating CO2 to form protons and bicarbonate, but there is no deﬁnitive evidence for this
in solid tumours in vivo.
METHODS: We used 1H magnetic resonance spectroscopic imaging (MRSI) of the extracellular pH probe imidazolyl succinic acid
(ISUCA) to measure and spatially map extracellular pH in HCT116 tumours transfected to express CAIX and empty vector controls in
SCID mice. We also measured intracellular pH in situ with 31P MRS and measured lactate in freeze-clamped tumours.
RESULTS: CAIX-expressing tumours had 0.15 pH-unit lower median extracellular pH than control tumours (pH 6.71 tumour vs pH
6.86 control, P= 0.01). Importantly, CAIX expression imposed an upper limit for tumour extracellular pH at 6.93. Despite the
increased lactate concentration in CAIX-expressing tumours, 31P MRS showed no difference in intracellular pH, suggesting that CAIX
acidiﬁes only the tumour extracellular space.
CONCLUSIONS: CAIX acidiﬁes the tumour microenvironment, and also provides an extracellular pH control mechanism. We
propose that CAIX thus acts as an extracellular pH-stat, maintaining an acidic tumour extracellular pH that is tolerated by cancer
cells and favours invasion and metastasis.
British Journal of Cancer (2018) 119:622–630; https://doi.org/10.1038/s41416-018-0216-5
BACKGROUND
We report the ﬁrst direct in vivo observation of the isoenzyme
carbonic anhydrase IX (CAIX) acting as a pH-stat that sets the
extracellular pH (pHe) of solid tumours at an acidic level. This is
important because the acidic pHe can be tolerated by tumour cells
but it inhibits growth of normal host cells, thus facilitating invasion
and metastasis.1,2
It has long been established that tumour extracellular ﬂuid is
acidic3,4 but it had not previously been possible to demonstrate a
biological pH-stat mechanism by which tumours could stabilise
pHe. Early discussions about tumour acidiﬁcation focussed on the
lactic acid formed from glucose by aerobic glycolysis (i.e.,
glycolysis that takes place in tumour cells even at an oxygen
concentration high enough to permit oxidative metabolism), a
mechanism known as the “Warburg Effect”5,6 that is widely
regarded as a tumour characteristic.7 However, calculations of the
output of lactic acid and of CO2 from tumours monitored in vivo
8
suggested that tumour CO2 output is comparable to or greater
than that of lactate. Human xenografts in nude rats produced
588–850 nmol/g/min CO2 vs 527 nmol/g/min lactate (calculated
from data in Kallinowski et al.9), whereas colonic tumours in
human patients produced 1296 nmol/g/min CO2 vs 220 nmol/g/
min lactate (calculated from data in Holm et al.10). Since CO2 can
be hydrated to form H+ and HCO3
− in the extracellular ﬂuid, in a
reaction catalysed by the exofacial (i.e., expressed on the outer
surfaces of cells) isoenzyme CAIX, CO2 production would tend to
acidify pHe. The present study has demonstrated this mechanism
in vivo.
In recent years, an understanding of why CO2 hydration might
be important in cancer tissue has begun to emerge from in vitro
studies on spheroids composed of CAIX-expressing cancer cells, in
which CAIX catalysis reduced pHe and raised intracellular pH
(pHi).
11,12 In vivo studies on solid tumours using positron-emission
tomography imaging with pH-sensitive low insertion peptides
(pHLIP), which are known to bind to cells in more acidic
environments, have shown decreased uptake and retention of
pHLIP in tumours when CAIX is inhibited by acetazolamide
(ATZ).13 However, studies attempting to directly measure the
effect of CAIX expression on pHe in solid tumours, by using the
31P
magnetic resonance spectroscopy (MRS) probe 3-aminopropionic
acid (3-APP)13–15 and hyperpolarized 13CO3
− 1H MRS,15 have thus
far been unable to deﬁnitively demonstrate an acidifying
effect of CAIX on pHe, probably due to technical limits in the
resolution and sensitivity of those methods. Hence, causal
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evidence for CAIX acidifying the tumour microenvironment in vivo
has been lacking.
Another long-standing puzzle is whether the acidic pHe of the
tumour extracellular ﬂuid is homeostatically controlled at a
particular set point and, if so, how that is accomplished. Stubbs
et al.16 postulated the existence of an extracellular pH-stat as a
homeostatic mechanism for pHe that would curtail excessive acid
loading, and recent studies have suggested that the ability of
cancer cells to modulate the set point of tumour pHe may be an
evolutionary strategy to achieve a stable state favouring invasion
in response to microenvironmental selection pressures.17,18
Several in vitro studies have suggested that the properties of
CAIX ﬁt it for a role as an extracellular pH-stat.12,17,19 No published
study has yet directly demonstrated such a mechanism in vivo,
however.
We used the probe ISUCA ((±)2-(imidazol-1-yl) succinic acid)
which reports tissue pHe from the ratio of its protonated and
unprotonated forms, measured from the pH-sensitive chemical
shift of its H2 proton (Fig. 1); it has previously been used to map
pHe in rat brain tumours.
20 ISUCA has rapid, carbonic anhydrase
(CA)-independent H+ equilibration properties, and does not enter
the cell, so it reports on pHe with no contaminating signal from
pHi.
20 Furthermore, since the 1H MRS used with ISUCA is about 15-
fold more sensitive than the 31P MRS used with 3-APP, it is
possible to monitor the pHe of multiple voxels in a tumour (and to
discard those with inadequate ISUCA uptake or contamination by
non-tumour tissues), whereas 3-APP studies usually obtain only a
single reading from a voxel encompassing the whole tumour.
Using 1H MRS imaging to detect ISUCA, we were able to
measure pHe from multiple voxels in HCT116 colorectal tumour
xenografts in mice bearing a tumour model in which all cells
expressed CAIX (CA9 tumours) and also size-matched empty
vector (EV) tumours that expressed lower levels of CAIX only in
hypoxic areas (note that we use CAIX for the carbonic anhydrase
IX enzyme, CA9 for the corresponding gene and CA9 for the
HCT116 tumour line that constitutively expresses the enzyme).
Hence, the entire extracellular viable volume of CA9 tumours was
inﬂuenced by expression of CAIX, compared with the relatively
small volume in EV tumours where CAIX was induced only at the
hypoxic margin.
We observed that CAIX expression in the CA9 tumours imposed
an upper limit on tumour pHe, thus lowering the steady-state pH
in their extracellular space. Furthermore, we demonstrated that
CAIX acidiﬁes only the extracellular space, since 31P MRS
measurements showed no difference in tumour pHi despite
increased lactate production. Our ﬁndings thus constitute
deﬁnitive evidence for the long-postulated roles of CAIX in both
acidifying the tumour microenvironment and acting as a pH-stat
for it.
MATERIALS AND METHODS
Cell culture
HCT116 cancer cells transfected with the CA9 gene coding
sequence (HCT116-CA9) or an empty vector (HCT116-EV) were
grown in culture as described previously.12 The cell lines were
provided by Professor A.L. Harris (November 2008) and their
identities were veriﬁed by short tandem repeat analysis using the
PowerPlex 18 Primer Kit (Promega) and their amplicons separated
by capillary electrophoresis on AbiPrism genetic analysers. Cells
were routinely tested for mycoplasma contamination.
pHe gradient measurements in 3D cell spheroids
HCT116 cell spheroids (radius 120–130 µm) were cultured using
the hanging drop method described previously.21 Radial pHe
measurements were performed on these spheroids by confocal
microscopy (pixel volume of 2 × 2 µm), using a published
method.11 Measurements were performed in the presence or
absence of ISUCA (13.3 mM). The dye was membrane-tethered
WGA (wheat germ agglutinin) conjugated ﬂuorescein, excited at
488 nm and emission collected above 520 nm (ﬂuorescence is
quenched at low pH).
The average radial pHe gradients were measured in control
spheroids (treated with the CA inhibitor ATZ only) and in
spheroids incubated with ISUCA (13.3 mM) and ATZ for 2 h (n=
29). The diffusion coefﬁcient of ISUCA (DISUCA) was estimated using
a published modelling framework.11 To investigate the magnitude
of pH measurement error introduced by ISUCA, pHe at the core of
the spheroid mass was simulated for a model spheroid under
different experimental conditions, using a previously published
quantitative diffusion-reaction model.11
Tumours
All animal experiments were performed under UK Home Ofﬁce
Licences 80/2203 and 70/7676. Tumours were grown subcuta-
neously as described previously12 but in female severe combined
immunodeﬁcient (SCID) mice (CB17/lcr-Prkdcscid/lcrCrl) obtained
from Charles River Laboratories (Margate, UK) at 6 to 8 weeks of
age. Tumours were initiated after a minimum of 7 days post-
delivery acclimatisation and scanned at a volume of 300–500
mm3. Mice were housed in individually ventilated cages, up to 5
per cage, with food and water ad libitum and kept under a
light–dark cycle.
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Fig. 1 Structural formula and NMR characteristics of the pHe probe
ISUCA. a Structural formula of ISUCA, indicating the position of the
H2 (red arrow), H4 AND H5 nuclei on the imidazole ring. b In vitro 1H
MR spectra of ISUCA at different pH values in murine plasma at 37 °
C, showing changes in chemical shift of the H2 peak with changes in
pH. c pH calibration curve of the chemical shift of the ISUCA H2 peak
in plasma at 37 °C, ﬁtted to the Henderson–Hasselbalch equation
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In vitro characterisation of ISUCA
The chemical synthesis of ISUCA and generation of a pH
calibration curve using the chemical shift of the ISUCA H2 proton
have been previously described.20 The spectrum contains three
peaks of equal area for the H2, H4 and H5 protons (Fig. 1a); the
chemical shift of the H2 peak is most pH sensitive (Fig. 1b), and
this peak was used for pH measurement relative to the water
resonance, which served as the internal standard. Calibration of
pH was conﬁrmed on a 600MHz Bruker AVANCE NMR Spectro-
meter (Bruker Biospin, Coventry UK), using solutions of ISUCA in
murine plasma at 37 °C with pH values over the range 2.06–9.44
(Fig. 1c).
Measurement of membrane CA catalytic activity
CA catalytic activity was determined on intact HCT116, EV and CA9
cells in the presence and absence of 100 μM ATZ by means of live-
cell ﬂuorescence imaging methods published previously.11 In
previous studies on the HCT116 line we had shown that its CAIX
activity was inhibited by AP105, a CAIX-speciﬁc inhibitor,11 and
that exofacial CA activity in these cells is blocked by a CAIX-
speciﬁc monoclonal antibody.22 The CA-catalysed CO2 hydration
rate was determined in fractionated cell lysates, using a previously
published activity assay.23
In vivo magnetic resonance spectroscopy of tumours
We devised an experimental protocol for the delivery and
detection of ISUCA in tumour-bearing mice, followed by
automated chemical shift assignment and peak quantitation of
the ISUCA H2 peak by 1H MRS imaging (MRSI), which permitted
direct in vivo measurement and spatial mapping of the voxel-wise
distribution of pHe. This method allowed us to obtain data from
multiple voxels in each tumour and to discard any in which the
ISUCA concentration was inadequate or in which skeletal muscle
was present in the T2-weighted image.
Our method requires consistent delivery of high ISUCA
concentrations into the tumour extracellular space, so timing of
ISUCA delivery is crucial for obtaining spectra of adequate quality.
For 1H MRS of ISUCA to measure pHe, anaesthesia was induced by
inhalation of 2% isoﬂurane in oxygen and maintained with 1.0 to
1.5% isoﬂurane. With the mouse in an appropriate jig, the tumour
was positioned centrally in a 20 mm-diameter receive-only surface
coil (Rapid Biomedical, Rimpar, Germany). Respiratory rate was
monitored using a pneumatic pillow sensor; body temperature,
monitored with a rectal probe, was maintained at 37 °C with
feedback-controlled warm air delivery (SA Instruments Inc., Stony
Brook, NY). The entire assembly was inserted in a 1H quadrature
volume coil (Rapid Biomedical), positioned inside a horizontal-
bore 9.4-Tesla magnet, interfaced to an MRI system scanner
console (Agilent, Yarnton, UK) running VnmrJ 3.1 NMR acquisition
and processing software.
T2-weighted fast spin echo images were acquired in the axial,
coronal and sagittal planes (repetition time (TR) 2000ms; echo
time (TE) 40 ms; ﬁeld of view (FOV) 30mm× 30mm; data matrix
256 × 256; slice thickness 1 mm with 0.5 mm gaps; 5–7 interleaved
imaging slices). A volume of interest (VOI) measuring 30 × 30 × 5
mm3 was carefully oriented to encompass the tumour in the
coronal plane. Localised shimming resulted in a water peak with a
line-width of typically 60–80 Hz.
After shimming, a 200 µl bolus of ISUCA solution (1.4 M, pH 7.2)
was administered via a pre-inserted peritoneal cannula. An
unsuppressed water reference spectroscopic image was then
acquired for magnetic ﬁeld inhomogeneity correction. At 20 min
after ISUCA administration, 1H MRSI was performed on the VOI to
acquire ISUCA spectra from the tumour, using the PRESS-CSI
sequence (TR= 1.5 s; TE= 30ms; FOV 30mm× 30mm; 16 × 16
phase encoding steps, 8 averages, sweep width 4032 Hz; slice
thickness 5 mm, voxel volume 17.6 µl, acquisition time 52min).
VAPOR (variable power and optimised relaxation delays) water
suppression24 was employed. Preliminary experiments showed
that this timing afforded suitable tumour ISUCA concentrations
during the acquisition.
31P MRS experiments to measure pHi were carried out in a
separate cohort of mice, as the total experimental duration for
both studies in the same mouse would have exceeded animal
welfare limits. Preparation for the study was similar to that for the
1H study, except that the mice were scanned in a 40mm inside-
diameter Millipede volume imaging coil (Agilent) with a custom-
made three-dimensional (3D)-printed insert containing a 25mm
31P surface coil, which enclosed the tumour. ISIS (image-selected
in vivo spectroscopy) localisation was used with 8 ms hyperbolic
secant adiabatic inversion pulses and 5ms BIR-4 adiabatic
excitation pulses. Outer volume suppression was employed to
minimise contamination from adjacent tissues. The median voxel
volume in these single-voxel studies was 250 µl. No exogenous
agent was injected, as the pHi was calculated from the chemical
shift of the inorganic phosphate (Pi) peak, which varies with pH in
the physiological range and is predominantly detected from the
intracellular volume.25 See Supplementary Methods for details of
spectroscopic data processing. Tumour lactate was assayed
colourimetrically, see Supplementary Methods.
After data acquisition, the mouse was immediately killed and
the tumour excised and ﬁxed.
Histopathology
Tumours were excised immediately after pH spectroscopy, ﬁxed
for 24 h in 10% formalin and embedded into parafﬁn blocks (Leica
ASP300S automated processor). The 3 µm sections were cut and
where possible adjacent sections were stained with haematoxylin
and eosin and for CAIX and Ki67. Automated immunohistochem-
istry was performed on a Leica BOND-MAX system. The CAIX
antibody (monoclonal mouse anti-human, M75 clone) was a gift
from Dr. Pastorek, Bratislava, Slovakia, and was used in a 1:100
dilution with pH 6.0 citrate buffer antigen retrieval; the Ki67
antibody (monoclonal mouse anti-human, Dako M7240) was used
in a 1:200 dilution with pH 9.0 Tris-EDTA antigen retrieval. DAB
enhancer (Leica 9432) was used for both antibodies. Slides were
scanned using the Aperio (UK) ScanScope system at ×20
magniﬁcation.
Lactate analysis
Tumours (CA9 constitutive expressers and EV5 empty vectors)
were excised from terminally anesthetised mice and immediately
freeze-clamped using tongs previously immersed in liquid
nitrogen. Samples were powdered in liquid nitrogen and
extracted with 4 volumes of 6% perchloric acid followed by
centrifugation and neutralisation. Lactate was assayed in the
extracts using the L-Lactate Assay Kit (Colorimetric) ab65331
(Abcam) according to the manufacturer’s instructions. Since
lactate is a passively distributed solute, total tissue measurements
cannot attribute its location relative to the cell membrane. The pH
distribution was therefore used to infer the intracellular to
extracellular lactate gradient.
Statistics
Statistical analyses were performed using GraphPad Prism soft-
ware, Version 5.01 (GraphPad Software, Inc., La Jolla, CA, USA). For
pH or rate constant data, differences between means were tested
by a two-tailed t-test. For animal experiments, statistical differ-
ences were tested with the non-parametric Mann–Whitney test,
while correlations were tested with the non-parametric Spear-
man’s rank correlation coefﬁcient. For the in vitro studies, the data
are presented as the means ± standard errors and were tested for
statistical differences with a two-tailed t-test. Differences were
considered statistically signiﬁcant if P < 0.05.
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RESULTS
Using ﬂuorescent dye measurements of cell surface pH transients
in response to a 30 s pulse of NH3/NH4
+-containing buffer, we
veriﬁed the presence of exofacial carbonic anhydrase activity in
CA9 cells (Fig. 2ai) and its absence in EV cells in vitro (Fig. 2aii). ATZ
(100 µM) was added to block CA activity and interrogate pH
transients in the absence of CA catalysis. NH3/NH4
+-evoked pHe
transients were signiﬁcantly smaller (i.e., better buffered) in CA9
cells (Fig. 2aiii). Note that ATZ is membrane permeable, but
inhibition of intracellular CAs cannot meaningfully affect extra-
cellular pH dynamics; therefore, its inhibitory effect is attributable
only to exofacial catalytic sites. Using a functional assay for CA
activity, CA9 cell membrane fragments were shown to signiﬁcantly
accelerate CO2 hydration rate, whereas EV membranes showed no
catalytic activity (Fig. 2b). The exofacial CA activity in CA9 cells was
comparable to endogenous levels of membrane CA activity in
wild-type MDA-MB-468 breast cancer cells, a cancer cell line
known to constitutively express CAIX (Fig. 2b), which conﬁrms that
CAIX-transfected HCT116 cells have exofacial CA activity in the
physiological range.
EV tumours expressed CAIX only in cells around hypoxic
regions, whereas CAIX was uniformly expressed by all viable CA9
tumour cells (Fig. 3), as had been found by McIntyre et al.12 We
mapped the pHe of CA9 and EV tumours in vivo by
1H MRSI of the
1H MRS probe ISUCA. Mapping 5mm-thick spectroscopic images
of in vivo pHe onto MRI images of CA9 and EV tumours (Fig. 4a;
Supplementary Figures 1 and 2) revealed a median pHe of 6.71 in
the CA9 tumours (n= 8), which was signiﬁcantly more acidic (P=
0.001, Mann–Whitney test) than the median pHe of 6.86 in the EV
tumours (n= 9) (Fig. 4b, c). The range of pHe values in CA9
tumours was 6.23 to 6.93, whereas the range of pHe values in EV
tumours was 6.20 to 7.53. Intriguingly, we observed a striking
absence of any pHe value above pH 6.93 in the CA9 tumours,
whereas 27% of the EV tumour pHe values were above that cut-off
value (Fig. 4d). These results suggest that CAIX expression by
HCT116 cells imposes an upper pHe limit in solid tumours, akin to
the action of a pH-stat.
To conﬁrm our conclusions, we investigated whether the
presence of ISUCA in the extracellular ﬂuid affects the accuracy
of tumour pHe measurements. ISUCA was capable of buffering
absolute changes in pH in cell spheroids but only slightly
diminished the size of the pHe gradients (Supplementary
Figure 3A, B) The average ISUCA concentration in tumours (13.3
mM, Supplementary Figure 4A) only accelerated CAIX activity in
spheroids by 12% (Supplementary Figure 3C), possibly because
this imidazole derivative may augment the transfer of H+ ions
between the bulk solution and the catalytic site.26 Despite these
minor effects, the lack of positive correlation between ISUCA
concentration and tumour pHe suggests that ISUCA is unlikely to
have a signiﬁcant effect on the magnitude of facilitated CO2
diffusion in vivo (Supplementary Figure 4B, C and D). In silico
modelling of pHe dynamics at the core of spheroids suggests that
the presence of ISUCA may lead to a minor underestimation of
extracellular acidiﬁcation (Supplementary Figure 5). Collectively,
these lines of evidence suggest that the increased acidiﬁcation
observed in CA9 tumours is unlikely to be due to artefacts induced
by the chemical buffering properties of ISUCA. Furthermore, even
if one of these potential artefacts were to have an unexpectedly
large effect, it would only induce spurious results if higher
concentrations of ISUCA were present in one of the tumour types,
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Fig. 2 Exofacial CA activity in HCT116 CA9 cells is in the
physiological range of activity. a Exofacial pH transients measured
with surface membrane-tagging WGA ﬂuorescein in response to a
30 s pulse of 30mM NH3/NH4
+-containing superfusate, measured in
(i) intact HCT116 CA9 cells (n= 15) and (ii) intact HCT116 EV cells (n
= 9), compared with paired runs in the presence of 100 µM ATZ, a
broad-spectrum inhibitor of CA activity. (iii) Mean data for the peak
and nadir of pHe transients in CA9 and EV cells, compared to the
responses during ATZ inhibition. pH changes were smaller (i.e.,
better buffered) in CA9 cells, indicating membrane-bound CA
activity. b CO2 hydration rates, normalised to protein concentration,
measured in the cytoplasmic (C) and membrane (M) fractions of EV
or CA9 HCT116 cells, compared to wild-type MDA-MB-468 cells, a
cell line that naturally expresses CAIX in normoxia. Measurements
performed on triplicate of independently harvested monolayers.
Dashed line indicates spontaneous activity measured in buffer only
(no cellular material). Red data points show values for each cell line
after inhibition with 100 µM ATZ, showing reduction to spontaneous
levels. Error bars are SEM. *indicates p<0.05 for the difference
between C and M fractions and spontaneous activity in buffer alone
(which is shown by the dashed line)
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whereas we found that there was no signiﬁcant difference in these
concentrations (Supplementary Figure 4A).
To investigate whether extracellular acidiﬁcation was accom-
panied by intracellular alkalinisation in vivo, we obtained the pHi
of CA9 and EV tumours from 31P MRS measurements of the
endogenous inorganic phosphate signal, the chemical shift of
which is pH sensitive in the physiological range and which
predominantly arises from the intracellular compartment of
tumours.3 The ranges of pHe and pHi values in the CA9 tumours
(Fig. 5) show minimal overlap, demonstrating that markedly
differing extracellular and intracellular pH environments were
probed, and we found no detectable differences between the pHi
values of the CA9 tumours and the EV tumours (7.00 ± 0.04 vs 6.99
± 0.04; mean ± SEM; Fig. 6a).
To conﬁrm the validity of our pH imaging results, we performed
a biochemical assay for lactate to test whether there are
differences in lactate retention between CA9 and EV tumours.
Lactate ions are known to distribute passively across the cell
membrane, both in tumour cells27 and solid tumours,28 trans-
ported by MCT proteins,29 with the intracellular to extracellular
lactate concentration ratio depending on the transmembrane pH
gradient. Cells bathed in a more acidic milieu, such as CA9
tumour cells, are therefore expected to retain more lactate. We
measured total lactate concentrations in freeze-clamped CA9 and
EV tumours (see Supplementary Methods). The CA9 tumours had
signiﬁcantly higher total lactate content than the EV tumours
(10.01 ± 0.55 μmol/g, n= 10 vs 6.6 ± 0.89 µmol/g, n= 6; P= 0.01,
see Fig. 6b). Since the mean pHi and pHe for each tumour type are
known, we can therefore calculate the ratio of lactate on either
side of the membrane. Using the mean values from Fig. 6b we
calculate the intracellular and extracellular lactate values shown
in Fig. 6c: the CA9 tumours had markedly higher intracellular
lactate than the EV tumours, whereas the difference in
extracellular lactate was much less. This calculation assumed an
intracellular volume fraction of 0.6, but a sensitivity analysis
(Fig. 6d) shows qualitatively similar results across the full
reasonable range of intracellular volume fractions (0.4–0.8); for
comparison, Panagiotaki et al.30 reported intracellular volume
fractions of 0.84 ± 0.02 and 0.68 ± 0.02 in two other human
colorectal xenograft models.
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Fig. 3 CAIX is expressed in all viable CA9 tumour tissue (a) but only at the hypoxic necrotic/viable interface in EV tumours (b). For both (a) and
b: upper parts i, ii and iii show close-cut whole tumour sections, scale bar: 3 mm; lower parts iv, v and vi show higher magniﬁcation of the area
indicated by the black rectangle, scale bar: 800 µm. Parts i and iv: haematoxylin and eosin staining; viable areas are dark purple; necrotic areas
are pale. Parts ii and v: CAIX staining in brown, showing staining in all viable areas in CA9 tumours but absence of staining in the viable areas
of EV tumours. Parts iii and vi: Ki67 staining (for proliferating cells) in brown, which conﬁrms the proliferative areas and further deﬁnes the
hypoxic periphery of viable tissue, adjacent to necrosis. Necrotic areas are non-perfused and so do not give an ISUCA signal
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In conclusion, we demonstrated (i) that exofacial CAIX expres-
sion by HCT116 tumours resulted in reduced tumour pHe; (ii) that
the maximum pHe of their extracellular space was held below 6.93;
(iii) that their pHi was unaffected; and (iv) that they would
therefore retain intracellular lactate.
DISCUSSION
The HCT116 CA9 colorectal tumours uniformly expressing high
levels of CAIX protein, along with their EV counterparts in which
CAIX is induced only in hypoxic regions, offer a tractable
experimental platform to study the effect of CAIX expression on
tumour pHe in vivo, independent of changes in tumour
vascularity, oxygenation and metabolism. The CA9 tumours
present an adequate volume of viable tissue in which pHe is
inﬂuenced by CAIX to allow accurate pHe measurements that can
be compared with similar volumes of EV tissue which have much
less CAIX expression. Using the ISUCA method, we have obtained
multiple pHe values from each tumour and discarded voxels with
inadequate ISUCA uptake or skeletal muscle contamination. Our
results thus provide strong evidence that exofacial expression of
CAIX on cancer cells results in a lower pHe. We have also shown
that exofacial CAIX catalysis acts in vivo as a pH-stat mechanism
that tends to maintain a mildly acidic pHe. We infer that this will
occur not only within regions of solid tumours in which CAIX is
expressed because of hypoxia, but also in any other area where
CAIX is expressed independently of hypoxia. While CAIX is usually
associated with tumour hypoxia and frequently used as a hypoxia
marker, it is expressed in normoxia in the oestrogen receptor-
positive MCF7 cell line31 and multiple studies have shown that it
is often expressed in vivo in areas where hypoxia is not
detected.32–34
In previous studies on CAIX expression in HCT116 spheroids, the
extracellular acidiﬁcation was accompanied by an intracellular
alkalinisation.11 We therefore hypothesised that if extracellular
acidiﬁcation by CAIX activity was due to a transmembrane
redistribution of acidity, the intracellular compartment of CA9
tumours would be more alkaline than that of the EV tumours. The
absence of detectable differences between the pHi values of the
CA9 tumours and the EV tumours (7.00 ± 0.04 vs 6.99 ± 0.04; mean
± SEM) (Fig. 6a) suggests that exofacial CAIX expression has little
net effect on tumour pHi in vivo and that the effect of CAIX
expression is primarily on tumour pHe. This might be due to the
weaker buffering capacity and smaller volume of the extracellular
space compared with the intracellular space, both of which would
tend to amplify acid-load induced pHe changes. The calculated
intracellular and extracellular lactate concentrations (Fig. 6c)
predict that the more positive pHi–pHe gradient in CA9 tumours
would retain lactate intracellularly at the steady state, and this was
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demonstrated by measuring lactate in excised tumours (Fig. 6b)
and calculating intra- and extracellular lactate (Fig. 6c). Exofacial
carbonic anhydrases (mostly CAIX) facilitate CO2 diffusion across
extracellular spaces, and by doing so acidify the extracellular
space en route. The fall in pHe reduces the thermodynamic driving
force for removing lactate from cells and therefore raises
intracellular lactate. Notwithstanding the different methods for
assay, the minimal overlap in the pHe and pHi values of the CA9
tumours (Fig. 5) also demonstrates that ISUCA reports pHe in vivo,
substantiating the previous in vitro report in cultured C6 cells.20
The acidic pHe of solid tumours has been hypothesised to
advantage cancer cell growth by killing adjacent normal cells,
promoting extracellular matrix degradation and thus remodelling
normal tissue architecture and modulating various steps along the
invasion-metastasis cascade.1,2 Importantly, recent studies have
uncovered evidence for increased mitochondrial oxidative meta-
bolism (and thus CO2 production) in migratory/invasive cancer
cells35 and also in vivo in a variety of preclinical tumour
models36,37 and human cancers.38 Estrella et al.,39 using a
window-chamber model, conﬁrmed that tumours invaded the
normal tissue that was most acidic, at pHe values below a
threshold that ranged from 7.1 to 6.8 in individual mice (their
Fig. 2b, d). In our study 44% of the measured CA9 tumour pHe
values were below 6.7, whereas the EV tumours had only 15%
(Fig. 3), showing that CA9 tumours produced sufﬁcient CAIX-
related acidiﬁcation in vivo to favour invasion and/or metastatic
cell escape. This notion is supported by reports of reduction in the
incidence of metastases in breast cancer models by CAIX
inhibition40–42 and in a prostate cancer model by CAIX silencing.43
Thus, the pH-stat function of CAIX is likely to extend to the
growing margin of the solid tumour, distant from optimal oxygen
supplies, allowing leading-edge cells to set tissue pHe at a level
inhibitory to normal tissue and thus facilitating invasion of cancer
cells. CAIX is also known to be expressed in the lamellipodia at the
leading edge of motile normal cells and has been postulated to
acidify the adjacent extracellular ﬂuid,44 a mechanism that might
facilitate the invasion of motile cancer cells into the surrounding
normal tissue. Perhaps cancer cells induce extracellular acidiﬁca-
tion by co-opting a method used by normal cells to facilitate tissue
remodelling.
The idea that there should be a homeostatic mechanism that
maintains pHe within a physiologically appropriate range was
hypothesised by Stubbs et al.16 Recent publications have
suggested that CAIX could be acting as both the H+ ion generator
and the pH sensor in such a mechanism. Studies in vitro have
found CAIX to be active even at relatively acidic levels, with a pK of
6.4919 or 6.81–6.8612 and others have suggested that CAIX has its
highest catalytic activity at pH 6.817. Moreover, compared to other
CA isoforms, CAIX appears to be more sensitive to pH changes
near the pK, with a Hill cooperativity number of ~2; these
properties suit it ideally to the role of an acidic pH-stat.12,17 In
contrast, CAXII (another exofacial cancer-related isoform) is active
across the pH range and would not act as a pH-stat, since the
persistence of CAXII activity at low pHe, means that the reaction
will continue unopposed.45
This study constitutes the ﬁrst evidence from solid tumours
in vivo for the presence of a pH-stat mechanism, which, when
supplied with CO2, would tend to stabilise an acidic pHe within
CAIX-expressing regions of tumours. We propose, therefore, that
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whereas other membrane H+ transport mechanisms such as the
Na+/H+-exchanger and the vacuolar ATP-dependent H+ pump are
primarily concerned with maintaining a constant pHi, extracellular
CA catalysis endows CAIX-expressing cancer cells with the ability
to set the pH of their environment at an acidic level. We suggest
that this pH-stat mechanism may be found to operate in other
human cancers, and perhaps in other disease states involving
carbonic anhydrases, tissue ischaemia and pH changes, such as
ischaemic cardiomyopathy46 and diabetic retinopathy.47
Our ﬁndings support the involvement of CAIX in determining
tissue pHe, independently of hypoxia status, and add to the
therapeutic rationale for pharmacologically inhibiting CAIX, which
is already an emerging drug target.48 Abrogation of this pH-stat
function might reduce the acidity of the tumour microenviron-
ment and impinge on the downstream disease mechanisms
governed by this pathophysiologic feature of cancer.
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